Open AccessGuidelines for tuberculosis prophylaxis during anti‐tumour necrosis factor‐α treatment: Indian Rheumatology Association
Author(s) -
HANDA R.,
MISRA R.,
CHATURVEDI V. P.,
PISPATI P. K.,
RAO U. R. K.,
JOSHI V. R.
Publication year - 2006
Publication title -
aplar journal of rheumatology
Language(s) - English
Resource type - Journals
eISSN - 1479-8077
pISSN - 0219-0494
DOI - 10.1111/j.1479-8077.2006.00181.x
Subject(s) - medicine , rheumatoid arthritis , rheumatology , tuberculosis , tuberculin , population , family medicine , intensive care medicine , immunology , pathology , environmental health
India is home to a large patient population of both rheumatoid arthritis (RA) and tuberculosis (TB). As the usage of biologic agents in RA increases in India, the issue of TB reactivation and prophylaxis becomes very pertinent. The consensus view of an expert group from the Indian Rheumatology Association is presented. Tuberculin testing has limited utility in India and isoniazid prophylaxis seems to be a reasonable option. It is hoped that this report shall pave the way for formal guidelines.